ARC funds research that is relevant to TB, respiratory diseases due to other infections, and respiratory disease related to tobacco use.
Support is provided through the Harry Windsor Research Grants Scheme.
Since the 1990’s, ARC has provided in excess of $2.5 million in research funding to address a range of issues, including:
- New strategies for TB vaccination
- Rehabilitation for people with Chronic Obstructive Pulmonary Disease (COPD)
- Infant lower-respiratory tract infections
- Aboriginal children public health
ARC also awards the Ann Woolcock Fellowship which is offered for four years in order to provide full-time training in biomedical, clinical
or public health research. It is valued at up to $400,000 over a four year period.
ARC continues to support Australian scientists in their efforts to find innovative ways to prevent and treat serious respiratory diseases.